Spontan İntraserebral Kanamaların Acil Yönetimi
Özet
Spontan intraserebral kanama (SİSK), dünya genelinde her yıl 2 milyon kişiyi etkileyen, yüksek mortalite ve morbidite oranına sahip en ciddi inme türlerinden biridir. Temel etiyolojik nedenleri sistemik hipertansiyon ve serebral amiloid anjiyopatidir. Hipertansiyon değiştirilebilir risk faktörleri arasında ilk sırada yer alırken; diyabet, sigara ve alkol kullanımı diğer önemli faktörlerdir. Tanı sürecinde, hızlı erişilebilirliği ve maliyeti nedeniyle kontrastsız bilgisayarlı tomografi (BT) ilk tercih edilen yöntemdir. Hematom hacminin ABC/2 yöntemiyle hesaplanması ve İSK skoru gibi ölçeklerin kullanılması, prognozun öngörülmesinde kritiktir. Acil yönetimde en önemli hedeflerden biri, hematom genişlemesini önlemek amacıyla sistolik kan basıncının (genellikle 140 mmHg altına) kontrol altına alınmasıdır. Ayrıca, antikoagülan kullanan hastalarda bu ilaçların etkisini geri döndürecek spesifik tedavilerin (K vitamini, protrombin kompleks konsantresi vb.) uygulanması hayati önem taşır. Cerrahi müdahale ise özellikle yüzeyel kanaması olan, 65 yaş altı ve klinik durumu kötüleşen hastalarda ilk 24 saat içinde hayat kurtarıcı olabilir. Multidisipliner bir yaklaşım gerektiren SİSK yönetimi, hala fonksiyonel iyileşme açısından zorlu bir süreçtir.
Spontaneous intracerebral hemorrhage (SICH) is one of the most severe types of stroke, affecting approximately 2 million people worldwide annually and carrying high mortality and morbidity rates. The primary etiological causes are systemic hypertension and cerebral amyloid angiopathy. While hypertension is the leading modifiable risk factor, other significant factors include diabetes, smoking, and alcohol consumption. In the diagnostic process, non-contrast computed tomography (CT) is the preferred method due to its rapid accessibility and cost-effectiveness. Calculating hematoma volume using the ABC/2 method and utilizing scales like the ICH score are critical for predicting prognosis. A key objective in emergency management is controlling systolic blood pressure (typically below 140 mmHg) to prevent hematoma expansion. Additionally, for patients on anticoagulants, administering specific reversal treatments (such as Vitamin K and prothrombin complex concentrate) is vital. Surgical intervention can be life-saving within the first 24 hours, particularly for patients under 65 with superficial hemorrhages whose clinical status is deteriorating. SICH management requires a multidisciplinary approach and remains a challenging process regarding functional recovery.
Referanslar
Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health 2013; 1: e259–81
An SJ, Kim TJ, Yoon BW: Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke. 2017; 19(1): 3–10
Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circul Res 2017; 120: 439–448
Goeree R, Blackhouse G, Petrovic R, et al Cost of stroke in Canada: a 1-year prospective study. J Med Econ 2008; 8: 147–167
De Herdt V, Dumont F, Henon H, et al. Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology 2011;77(20): 1794–800
Yamada M. Cerebral amyloid angiopathy: emerging concepts. J Stroke. 2015;17:17–30
Muntner P, Carey RM, Gidding S, et al.: Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation. 2018; 137(2): 109–18
Mayer SA, Rincon F. Treatment of intracerebral haemorrhage. Lancet Neurol. 2005;4(10):662-672
Khan NI, Siddiqui FM, Goldstein JN, et al.: Association Between Previous Use of Antiplatelet Therapy and Intracerebral Hemorrhage Outcomes. Stroke. 2017; 48(7): 1810–7
Renoux C, Vahey S, Dell’Aniello S, et al.: Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage. JAMA Neurol. 2017; 74(2): 173–180.)( Endres M, Nolte CH, Scheitz JF: Statin Treatment in Patients With Intracerebral Hemorrhage. Stroke. 2018; 49(1): 240–6.
Charidimou C, Boulouis G, Roongpiboonsopit D, et al. Cortical superfical siderosis multifocality in cerebral amyloid angiopathy: a prospective study. Neurology 2017; 89: 2128–35
Moulin S, Labreuche J, Bombois S, et al. Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study. Lancet Neurol 2016; 15: 820–29.
Charidimou A, Gang Q, Werring DJ: Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry. 2012; 83(2): 124–37
Heeley E, Anderson CS, Woodward M, et al. Poor utility of grading
scales in acute intracerebral hemorrhage: results from the INTERACT2 trial. Int J Stroke 2015; 10: 1101–7
Hemphill JC 3rd, Bonovich DC, Besmertis L, et al. The ICH score: a simple, reliable
grading scale for intracerebral hemorrhage. Stroke 2001;32(4):891–7
Meyer DM, Begtrup K, Grotta JC. Recombinant activated factor VIIIHTI. Is the ICH score a valid predictor of mortality in intracerebral hemorrhage? J Am Assoc Nurse Pract 2015;27(7):351–5
Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369(9558):293-8
Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015;46(7):2032–60
Rodrigues MA, Samarasekera N, Lerpiniere C, et al. The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol 2018; 17: 232–40
Safatli DA, Gunther A, Schlattmann P, et al. Predictors of 30-day mortality in patients with spontaneous primary intracerebral hemorrhage. Surg Neurol Int 2016;7(Suppl 18):S510–7
Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996;27(8):1304–5
From Morotti A, Goldstein JN. Diagnosis and management of acute intracerebral hemorrhage. Emerg Med Clin North Am 2016;34(4):883–99
Smith EE, Nandigam KR, Chen YW, et al. MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage. Stroke 2010; 41: 1933–38
Osborn A. (2015). Osborn Beyin Görüntüleme, Patoloji ve Anatomi. ( Mehmet Tekşam, Banu Çakır, Çev. Ed.). Ankara: Dünya Tıp Kitapevi
Kamel H, Navi BB, Hemphill JC, 3rd. A rule to identify patients who require magnetic resonance imaging after intracerebral hemorrhage. Neurocrit Care. 2013;18(1):59-63.
van Asch CJ, Velthuis BK, Rinkel GJ, et al. Diagnostic yield and accuracy of CT angiography, MR angiography, and DSA for detection of macrovascular causes of intracerebral haemorrhage: prospective, multicentre cohort study. BMJ 2015; 351: h5762
Bekelis K, Desai A, Zhao W, Gibson D, Gologorsky D, Eskey C, et al. Computed tomography angiography: improving diagnostic yield and cost effectiveness in the initial evaluation of spontaneous nonsubarachnoid intracerebral hemorrhage. J Neurosurg. 2012;117(4):761-6
Kranz PG, Malinzak MD, Amrhein TJ. Approach to imaging in patients with spontaneous intracranial hemorrhage. Neuroimaging Clin N Am. 2018;28(3):353- 374
Demchuk AM,DowlatshahiD, Rodriguez-LunaD, et al. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CTangiography spot sign (PREDICT): a prospective observational study. Lancet Neurol. 2012;11(4):307-314.
Balami JS, Buchan AM. Complications of intracerebral haemorrhage. Lancet Neurol. 2012;11(1):101-118.
Dowlatshahi D, Demchuk AM, Flaherty ML, et al. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology 2011; 76: 1238–1244.
Li Q, Zhang G, Xiong X, et al.: Black Hole Sign: Novel Imaging Marker That Predicts Hematoma Growth in Patients With Intracerebral Hemorrhage. Stroke. 2016; 47(7): 1777–81.
Kuramatsu JB, Gerner ST, Schellinger PD, et al.: Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA. 2015; 313(8): 824–36.
Al-Shahi Salman R, Frantzias J, Lee RJ, et al. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and metaanalysis of individual patient data. Lancet Neurol 2018; 17: 885–894
Butcher KS, Jeerakathil T, Hill M, et al.: The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial. Stroke. 2013; 44(3): 620–6.
Qureshi AI, Palesch YY, Barsan WG, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. New Engl J Med 2016; 375: 1033–1043
Moullaali TJ, Wang X, Martin RH, et al. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data. Lancet Neurol 2019; 18: 857–864
Shoamanesh A, Lindsay M P, Castellucci L A, Canadian stroke best practice recommendations: Management of Spontaneous Intracerebral Hemorrhage 7th Edition Update 2020. International Journal of Stroke, 2021, Vol. 16(3) 321–341. DOI: 10.1177/1747493020968424
Thompson BB, Bejot Y, Caso V, et al. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology 2010; 75: 1333–42
Baharoglu MI, Cordonnier C, Al-Shahi Salman R, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet 2016; 387: 2605–13
Frontera JA, Lewin JJ 3rd, Rabinstein AA, et al.: Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: Executive Summary. A Statement for Healthcare Professionals From the Neurocritical Care Society and the Society of Critical Care Medicine. Crit Care Med. 2016; 44(12): 2251–7
Andrews CM, Jauch EC, Hemphill JC, 3rd, Smith WS, Weingart SD. Emergency neurological life support: intracerebral hemorrhage. Neurocrit Care. 2012;17 Suppl 1:S37-46.
Schreuder FH, Sato S, Klijn CJ, Anderson CS. Medical management of intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 2017; 88: 76–84
Beghi E, D’Alessandro R, Beretta S, Consoli D, Crespi V, Delaj L, et al. Incidence and predictors of acute symptomatic seizures after stroke. Neurology. 2011;77(20):1785-93.
Passero S, Rocchi R, Rossi S, Ulivelli M, Vatti G. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia. 2002;43(10):1175-80
Haapaniemi E, Strbian D, Rossi C, et al. The CAVE score for predicting late seizures after intracerebral hemorrhage. Stroke 2014; 45: 1971–76.
Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol 2006; 5: 53–63
Gregson BA, Broderick JP, Auer LM, Batjer H, Chen XC, Juvela S, et al. Individual patient data subgroup meta-analysis of surgery for spontaneous supratentorial intracerebral hemorrhage. Stroke. 2012;43(6):1496-504
Morgenstern LB, Demchuk AM, Kim DH, Frankowski RF, Grotta JC. Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology. 2001;56(10):1294-9.
Hallevi H, Albright KC, Aronowski J, Barreto AD, Martin- Schild S, Khaja AM, et al. Intraventricular hemorrhage: Anatomic relationships and clinical implications. Neurology. 2008;70(11):848-52
Sembill JA, Gerner ST, Volbers B, et al.: Severity assessment in maximally treated ICH patients: The max-ICH score. Neurology. 2017; 89(5): 423–31.
